HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Stefan T Engelter Selected Research
Stefan T Engelter Research Topics
Disease
60
Stroke (Strokes)
06/2022 - 11/2006
40
Ischemic Stroke
06/2022 - 09/2010
14
Atrial Fibrillation
01/2022 - 01/2016
10
Carotid Stenosis (Carotid Artery Stenosis)
11/2019 - 10/2008
9
Hemorrhage
01/2022 - 03/2014
8
Cerebral Hemorrhage
01/2022 - 03/2013
7
Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2022 - 07/2011
5
Blood Vessel Dissection
01/2021 - 09/2007
5
Infarction (Infarctions)
09/2020 - 01/2003
4
Brain Ischemia (Cerebral Ischemia)
09/2021 - 02/2013
2
Transient Ischemic Attack
01/2022 - 01/2022
2
Ischemia
09/2020 - 01/2011
2
Hematoma
11/2018 - 05/2017
2
Pathologic Constriction (Stenosis)
01/2017 - 01/2012
1
Leukocytosis (Pleocytosis)
10/2022
1
Hypertension (High Blood Pressure)
05/2022
1
Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
05/2022
1
COVID-19
01/2022
1
Chronic Renal Insufficiency
01/2022
1
Brain Infarction
01/2022
1
Embolic Stroke
01/2022
1
Epilepsy (Aura)
08/2021
1
Type 2 Diabetes Mellitus (MODY)
01/2020
1
Hypercholesterolemia
01/2020
1
Arterial Occlusive Diseases (Arterial Occlusive Disease)
05/2014
1
Leukoencephalopathies
02/2014
1
Atherosclerosis
01/2012
1
Cerebral Infarction
01/2011
1
Mannose-Binding Protein Deficiency
01/2011
1
Delirium
01/2010
1
Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2003
Drug/Important Bio-Agent (IBA)
27
Anticoagulants
IBA
01/2022 - 09/2007
15
Vitamin K
FDA Link
01/2022 - 09/2015
7
Tissue Plasminogen Activator (Alteplase)
FDA Link
09/2021 - 11/2006
5
Rivaroxaban
IBA
01/2022 - 01/2017
5
Biomarkers (Surrogate Marker)
IBA
01/2021 - 01/2003
5
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2020 - 02/2013
4
Pharmaceutical Preparations
IBA
01/2022 - 01/2017
4
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
01/2022 - 09/2020
4
Glucose (Dextrose)
FDA Link
Generic
11/2019 - 12/2009
3
C-Reactive Protein
IBA
10/2022 - 12/2009
3
N(4)-oleylcytosine arabinoside
IBA
11/2018 - 09/2015
2
Tenecteplase
FDA Link
05/2022 - 10/2021
2
Platelet Aggregation Inhibitors (Antiplatelet Drugs)
IBA
01/2022 - 09/2020
2
edoxaban
IBA
02/2021 - 01/2019
2
apixaban
IBA
02/2021 - 01/2019
2
Dabigatran
FDA Link
02/2021 - 01/2019
2
Blood Glucose (Blood Sugar)
IBA
01/2018 - 03/2014
2
2,6-dinitrotoluene (DNT)
IBA
01/2017 - 10/2013
2
4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)
IBA
03/2014 - 07/2011
1
Creatinine
IBA
01/2022
1
poly(dG-dA)n.poly(dC-dT)n (((GA)n))
IBA
01/2022
1
Cystatin C
IBA
01/2022
1
Fibrinolytic Agents (Antithrombotic Agents)
IBA
01/2021
1
Biological Products
IBA
01/2021
1
Phenprocoumon (Liquamar)
FDA Link
01/2021
1
Warfarin (Coumadin)
FDA Link
Generic
01/2021
1
Acenocoumarol
IBA
01/2021
1
Retinaldehyde (Retinal)
IBA
09/2020
1
Metformin (Glucophage)
FDA Link
Generic
01/2020
1
Antihypertensive Agents (Antihypertensives)
IBA
01/2020
1
Heparinoids (Heparinoid)
IBA
01/2019
1
Thrombomodulin
IBA
01/2018
1
activated protein C receptor
IBA
01/2018
1
Protein C
IBA
01/2018
1
Endothelial Protein C Receptor
IBA
01/2018
1
Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)
IBA
12/2017
1
Nucleotides
IBA
06/2017
1
Transforming Growth Factor-beta Type II Receptor
IBA
06/2017
1
Tranexamic Acid (AMCA)
FDA Link
03/2017
1
ORALIT (ORS)
IBA
05/2014
1
danaparoid (Orgaran)
FDA Link
01/2012
1
Mannose-Binding Lectin (Mannan-Binding Lectin)
IBA
01/2011
1
Complement System Proteins (Complement)
IBA
01/2011
1
Atrial Natriuretic Factor (ANF)
IBA
09/2010
1
Electrolytes
IBA
01/2010
Therapy/Procedure
25
Therapeutics
05/2022 - 10/2008
10
Endarterectomy (Thromboendarterectomy)
11/2019 - 10/2008
5
Secondary Prevention
01/2022 - 11/2016
5
Aftercare (After-Treatment)
11/2019 - 01/2017
3
Length of Stay
01/2022 - 01/2003
2
Polypharmacy
01/2022 - 01/2018
2
Thrombectomy
09/2021 - 01/2018
2
Stents
11/2019 - 10/2008
2
Time-to-Treatment
12/2009 - 08/2009
1
Punctures
06/2022
1
Patient Admission (Patient Admissions)
06/2022
1
General Anesthesia
01/2022
1
Neurological Rehabilitation
08/2021
1
Contraindications
11/2019
1
Diagnostic Equipment
09/2018
1
Treatment Delay
10/2013
1
Carotid Endarterectomy
01/2012
1
Conservative Treatment
01/2011